More articles about Diagnostics

Under a definitive merger agreement, Roche will acquire outstanding shares of Foundation's common stock for $137 per share.

Clinicians are using Roche's Cobas Omni Utility Channel to run lab-developed PCR tests alongside in vitro diagnostic kits, freeing valuable resources for labs.

The researchers designed a transcriptome sequencing assay that identifies clinically relevant gene fusions in 541 genes.

The Fusion module is an in-lab upgrade to Hologic's Panther instrument, which enables labs to extend the testing capabilities of their existing Panther. 

The immunofluorescence assays support the detection of anti-double-stranded DNA, which is a marker for systemic lupus erythematosus.

The FDA will consider the companion diagnostic application alongside data for Pfizer's talazoparib in BRCA-mutated advanced breast cancer.

Elizabeth Holmes also stepped down from her position as Theranos CEO on Friday, to be replaced by the company's general counsel David Taylor.

At the recent CVS, the two large health systems described introducing Cepheid platforms for flu testing across rural and satellite locations.

The researchers used multiple-reaction monitoring mass spec to create a more sensitive assay to AFP-L3, a protein marker for hepatocellular carcinoma.

The company is planning to submit the drug and a companion diagnostic that can identify patients with FGFR alterations with the FDA in the second half of 2018.

The assay can be used in conjunction with other laboratory and clinical findings to differentiate IBD from irritable bowel syndrome, the firm said.

They found that cMyC protein was more abundant than cardiac troponin in heart disease patients and that it could be used to quickly rule out heart attack.

The UK government aims to create six centers specializing in digital pathology, medical imaging or both, working together through a framework agreement.

With the California licensure, the company’s PCR-based Colvera colorectal cancer monitoring test is available in all US states except New York.

Inspirata plans to leverage Caradigm's software to accelerate the development of Inspirata's cancer big data platform called Cancer Information Data Trust.

The organization hopes a national library of simulation content will help lab training programs supplement clinical placement training with simulation.

FibroTx has developed two proprietary diagnostic platforms that enable measurements of soluble biomarkers directly from the skin surface.

The test is intended for use as the initial screen in the two-step testing process recommended by the CDC for detecting antibodies against B. burgdorferi.

The companies will offer free testing to  more rapidly identify individuals with certain mutations, supporting Inozyme's efforts to develop and test new treatments.

Physicians can now use the Dako PD-L1 IHC 22C3 pharmDx assay to identify cervical cancer patients who may benefit from the anti-PD1 immunotherapy.

Pages